The shrinking case for saw palmetto

dc.contributor.author	Ricco, Jason	eng
dc.contributor.author	Prasad, Shailendra	eng
dc.contributor.other	Family Physicians Inquiries Network	eng
dc.date.issued	2012	eng
dc.description.abstract	Advise men with benign prostatic hyperplasia (BPH) not to take saw palmetto for urinary symptoms. Explain that it has not been found to alleviate symptoms, even at triple the standard dose. Stength of recommendation: A: Based on evidence from a high-quality randomized controlled trial (RCT)1 and a 2009 meta-analysis.	eng
dc.identifier.uri	http://hdl.handle.net/10355/14847
dc.language	English	eng
dc.publisher	Family Physicians Inquiries Network	eng
dc.relation.ispartofcollection	Priority Updates to Research Literature (PURLs) (2012)	eng
dc.relation.ispartofcommunity	University of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Network	eng
dc.relation.ispartofseries	Journal of family practice, 61, no. 07 (July 2012): 418-420.	eng
dc.rights	OpenAccess.	eng
dc.rights.license	This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.	eng
dc.subject.other	Benign prostatic hyperplasia	eng
dc.subject.other	Saw palmetto	eng
dc.subject.other	Urinary tract	eng
dc.subject.other	Alternative medicine	eng
dc.title	The shrinking case for saw palmetto	eng
dc.type	Article	eng

Priority Updates to Research Literature (PURLs)
Priority Updates to Research Literature generate new evidence-based recommendations for practice for family physicians and other primary care clinicians.